PSFG
HALO icon

Park Square Financial Group’s Halozyme HALO Stock Holding History

Park Square Financial Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-75
Closed -$3.9K – 554
2025
Q2 		$3.9K Buy
+75
New +$4.27K ﹤0.01% 778
2025
Q1 		– Sell
-77
Closed -$3.68K – 1001
2024
Q4 		$3.68K Buy
+77
New +$3.95K ﹤0.01% 755

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Park Square Financial Group's HALO Position: Q3 2025 in Review

Park Square Financial Group sold out of Halozyme (HALO) in Q3 2025, closing a stake of 75 shares — an estimated $3.9K sold.

Park Square Financial Group first reported a position in HALO in Q4 2024 and held it in 2 quarters. The position peaked at $3.9K in Q2 2025. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

  • Park Square Financial Group reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
  • Park Square Financial Group sold 75 Halozyme shares in Q3 2025, an estimated $3.9K.
  • Park Square Financial Group first reported a position in Halozyme in Q4 2024 and held it in 2 quarters.
  • Park Square Financial Group's Halozyme position peaked at $3.9K in Q2 2025.
  • 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Park Square Financial Group's 13F filing for Q3 2025, filed 12 Nov 2025.